Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:
Schedule
Product: ReVia
Active Ingredient(s): Naltrexone 50mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Orphan Australia Pty Limited
Manufacturer(s): Du Pont Pharmaceuticals Company, Garden City, New York, United States of America
Dated this 23rd day of May 2000.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).